These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 23298964)
61. Common errors in the treatment of rheumatoid arthritis. Moller PW Drugs; 1981 Apr; 21(4):297-301. PubMed ID: 7227220 [No Abstract] [Full Text] [Related]
62. Effect of pregnancy and obstructive jaundice on inflammatory diseases: the work of P S Hench revisited. Crocker I; Lawson N; Fletcher J Ann Rheum Dis; 2002 Apr; 61(4):307-10. PubMed ID: 11874831 [TBL] [Abstract][Full Text] [Related]
63. Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation. Iafolla M Can Fam Physician; 2013 May; 59(5):505-9. PubMed ID: 23673587 [No Abstract] [Full Text] [Related]
64. Inflammation 2009-Ninth World Congress. Advances in inflammation research: part 2. 6-10 July 2009, Tokyo, Japan. Mason VL IDrugs; 2009 Sep; 12(9):532-4. PubMed ID: 19697266 [No Abstract] [Full Text] [Related]
65. Reply to "Response to 'Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders' by Hassan et al.". Jing S; Hassan W Cytokine; 2014 Dec; 70(2):199. PubMed ID: 25073579 [No Abstract] [Full Text] [Related]
66. [Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis]. Wu M; Li Y; Zhang P Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Apr; 43(4):374-6. PubMed ID: 26082375 [No Abstract] [Full Text] [Related]
67. Deforming polyarthropathy with excess deposition of cholesterol; report of a case. SCHERBEL AL; WILSON TE; HAZARD JB Cleve Clin Q; 1956 Jul; 23(3):200-11. PubMed ID: 13343508 [No Abstract] [Full Text] [Related]
68. Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients. Fornaro M; Cacciapaglia F; Venerito V; Lopalco G; Iannone F Ann Rheum Dis; 2020 Sep; 79(9):e104. PubMed ID: 31142479 [No Abstract] [Full Text] [Related]
69. The steroid excretion and metabolism in rheumatoid arthritis. BIRKE G; LARS-OLOF P Acta Med Scand Suppl; 1958; 341():107-8. PubMed ID: 13605634 [No Abstract] [Full Text] [Related]
70. Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. Gasparyan AY Curr Pharm Des; 2012; 18(11):1447-9. PubMed ID: 22364139 [No Abstract] [Full Text] [Related]
71. Free radicals in biological systems--a review orientated to inflammatory processes. Blake DR; Allen RE; Lunec J Br Med Bull; 1987 Apr; 43(2):371-85. PubMed ID: 3319034 [No Abstract] [Full Text] [Related]
72. Lipids in disease pathology, diagnosis & therapy. Lammers T; Noels H Adv Drug Deliv Rev; 2020; 159():1-3. PubMed ID: 33308647 [No Abstract] [Full Text] [Related]
73. Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. González-Gay MA; González-Juanatey C Ann Rheum Dis; 2014 Jul; 73(7):1281-3. PubMed ID: 24907362 [No Abstract] [Full Text] [Related]
74. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512 [TBL] [Abstract][Full Text] [Related]